By Drug Target Review2025-09-11T10:31:40
Researchers have developed the first high-throughput tool to rapidly profile RNA modifications – a breakthrough that could lead to more precise treatments for cancer and antibiotic-resistant infections.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-01-09T09:30:19
Sponsored by Sartorius
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud